Generation of an induced pluripotent stem cell (iPSC) line from a patient with maturity-onset diabetes of the young type 3 (MODY3) carrying a hepatocyte nuclear factor 1-alpha (HNF1A) mutation

Affiliations

• ¹ ESTeam Paris Sud, INGESTEM National IPSC Infrastructure, UPSud, Paris-Saclay University, Villejuif 94800, France; UMR-S 935, INSERM, University Paris Sud, Villejuif 94800, France; Gustave Roussy Institut, Department of Biopathology, Villejuif 94800, France; Paris Descartes University, Faculty Sorbonne Paris Cité, Faculté des Sciences Pharmaceutiques et Biologiques, Paris, France. Electronic address: [email protected].
• ² CNRS-UMR8199, Institut Pasteur de Lille, Lille, France; Lille University, Lille, France.
• ³ ESTeam Paris Sud, INGESTEM National IPSC Infrastructure, UPSud, Paris-Saclay University, Villejuif 94800, France; UMR-S 935, INSERM, University Paris Sud, Villejuif 94800, France.
• ⁴ ESTeam Paris Sud, INGESTEM National IPSC Infrastructure, UPSud, Paris-Saclay University, Villejuif 94800, France; UMR-S 935, INSERM, University Paris Sud, Villejuif 94800, France; Division of Hematology, APHP-Paris Sud University, Le Kremlin Bicêtre 94275, Villejuif 94800, France; Paris Sud University, UPsud, Faculty of Medicine, Le Kremlin Bicêtre 94275, France.
• ⁵ CNRS-UMR8199, Institut Pasteur de Lille, Lille, France; Lille University, Lille, France; Department of Genomics of Common Disease, School of Public Health, Imperial College London, Hammersmith Hospital, London, United Kingdom.